2026 ICD-10-CM Diagnosis Code Q99.2Fragile X chromosome
ICD-10-CM Codes›Q00-Q99›Q90-Q99›Q99
- Billable — Valid for Submission
- POA Exempt
- Chronic Condition
Q99.2 is a billable ICD-10-CM diagnosis code for fragile X chromosome. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Chromosomal abnormalities.
Code Identity
Code Classification
Present on Admission (POA)Billing
Q99.2 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Dementia due to chromosomal anomaly
- Dementia due to fragile X syndrome
- Dementia due to genetic disease
- Fragile X associated primary ovarian insufficiency
- Fragile X associated tremor ataxia syndrome
- Fragile X chromosome
- Fragile X syndrome
- FRAXE intellectual disability syndrome
- FRAXF syndrome
- Premature ovarian failure
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Fragile X syndrome
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- X chromosome - Q99.2
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Fragile, fragility
- X chromosome
- Syndrome
- fragile X
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Fragile X Syndrome
a condition characterized genotypically by mutation of the distal end of the long arm of the x chromosome (at gene loci fraxa or fraxe) and phenotypically by cognitive impairment, hyperactivity, seizures, language delay, and enlargement of the ears, head, and testes. intellectual disability occurs in nearly all males and roughly 50% of females with the full mutation of fraxa. (from menkes, textbook of child neurology, 5th ed, p226)Fragile X Syndrome
a genetic syndrome caused by mutations in the fmr1 gene which is responsible for the expression of the fragile x mental retardation 1 protein. this protein participates in neural development. this syndrome is manifested with mental, emotional, behavioral, physical, and learning disabilities.
Patient EducationClinical
Fragile X Syndrome
Fragile X syndrome is the most common form of inherited developmental disability. A problem with a specific gene causes the disease. Normally, the gene makes a protein you need for brain development. But the problem causes a person to make little or none of the protein. This causes the symptoms of Fragile X.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert Q99.2 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About Q99.2Overview
Is Q99.2 (Other chromosome abnormalities, not elsewhere classified) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report fragile X chromosome on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Is Q99.2 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for fragile X chromosome on inpatient claims.
What is the ICD-9 equivalent of Q99.2?
Under the General Equivalence Mappings, fragile X chromosome converts to ICD-9-CM 759.83 (fragile x syndrome). The mapping is a direct match.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
